Cyclica
From Molecule to Medicine.
Overview
Cyclica, now part of Recursion, has developed an integrated, AI-augmented drug discovery platform that focuses on polypharmacology. Their platform uses a proteome-wide lens to evaluate the on- and off-target interactions of small molecules, providing insights into a drug's mechanism of action and potential side effects. This approach aims to make drug discovery faster, safer, and cheaper.
✨ Key Features
- Ligand Express® platform
- Polypharmacology prediction
- Proteome-wide screening
- Structure-based and AI-driven approach
- MatchMaker™ deep learning engine
🎯 Key Differentiators
- Focus on polypharmacology and proteome-wide screening.
- Integrated platform combining biophysics and AI.
- Ability to predict both on- and off-target interactions.
Unique Value: Provides a comprehensive view of a molecule's interactions across the entire proteome, enabling a more holistic and predictive approach to drug discovery.
🎯 Use Cases (5)
✅ Best For
- Has been used in numerous academic and industrial collaborations.
💡 Check With Vendor
Verify these considerations match your specific requirements:
- NA
🏆 Alternatives
Goes beyond single-target interactions to embrace the complexity of disease and drug action.
💻 Platforms
🔌 Integrations
🛟 Support Options
- ✓ Email Support
- ✓ Dedicated Support (Enterprise tier)
💰 Pricing
Free tier: NA
🔄 Similar Tools in AI for Drug Discovery
Atomwise
Utilizes deep learning for structure-based drug discovery to find small molecule hits....
Insilico Medicine
An end-to-end AI-driven drug discovery platform covering target identification, molecule generation,...
Recursion Pharmaceuticals
Industrializes drug discovery by combining automated biology with artificial intelligence....
Schrödinger
Provides a physics-based software platform for molecular discovery and design....
Valo Health
A technology company using human-centric data and AI to transform drug discovery and development....
BenevolentAI
Applies AI and machine learning to analyze biomedical information and accelerate drug discovery....